At a glance
- Originator Nonindustrial source
- Class Antivirals
- Mechanism of Action RNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 23 Apr 2002 No development reported - Preclinical for HIV infections treatment in France (PO)
- 29 May 2000 Preclinical development for HIV infections treatment in Belgium (PO)
- 29 May 2000 Preclinical development for HIV infections treatment in France (PO)